Pfizer
3 articles

Health & Medicine
Pfizer's obesity drug shows potential for monthly dosing
Mid-stage study data reveals Pfizer's experimental obesity drug, berobenatide, could achieve significant weight loss with a groundbreaking monthly dosing schedule, a stark contrast to current weekly o
Aram Sarkisian·June 7, 2026

Cosmos & Space
BioNTech, Pfizer Share Bispecifics Data at ASCO
BioNTech's BNT142 achieved 7 RECIST 1.
Aram Sarkisian·May 31, 2026

Cosmos & Space
Pfizer partners with Innovent Biologics for drug pipeline
Pfizer has committed up to $10.5 billion to a collaboration with Innovent Biologics in China to advance a pipeline of 12 novel therapies.
David Grossman·May 30, 2026